# DAPTOMYCIN
> **ANDA212250** · Abbreviated New Drug Application (Generic) · Sponsor: HISUN PHARM HANGZHOU · Approved 2021-04-21
## Drug
- **FDA Application Number:** ANDA212250
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPTOMYCIN
- **Generic name:** DAPTOMYCIN
- **Active ingredients:** DAPTOMYCIN
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HISUN PHARM HANGZHOU
- **Manufacturer:** Hisun Pharmaceuticals USA, Inc.
- **First approval:** 2021-04-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212250)
---
*AI Analytics · CC0 1.0*